How a ‘Christmas miracle’ became a nightmare for heart-failure patients By: MarketWatch April 25, 2017 at 05:25 AM EDT Congress inadvertently reduced funding for home infusion patients, leaving many with a bleak future, writes Daniel E. Greenleaf. Read More >> Related Stocks: Bioplus Acquisition Corp Cl A CVS Health Corp UnitedHealth Group Walgreens Boots Alliance